A Single-arm, Open, Single-center Exploratory Study of Adebrelimab (SHR-1316) in Combination with Chemotherapy for the Perioperative Treatment of Locally Advanced Resectable Esophageal Squamous Carcinoma
Latest Information Update: 14 Mar 2025
At a glance
- Drugs Adebrelimab (Primary) ; Cisplatin; Paclitaxel
- Indications Oesophageal cancer; Squamous cell cancer
- Focus Adverse reactions; Therapeutic Use
- 14 Mar 2025 New trial record